drugset / Trial / NCT03813095
Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is determine the safety, efficacy and tolerability of a novel drug APH-1501 as a pharmacotherapy for Opioid Dependence. The investigators will evaluate the safety of escalating doses APH-1501.
Timeline
- Start
- 2023-10
- Primary completion
- 2025-09
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | APH-1501 | Unknown | 400 mg | Oral |
| Subject | APH-1501 | Unknown | 600 mg | Oral |
| Subject | APH-1501 | Unknown | 800 mg | Oral |